← FDA Drug Approvals (Drugs@FDA)

IMIPENEM AND CILASTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA INC · Approved 2011-11-16

Drug application

FDA Application #

ANDA091007

Application type

Abbreviated New Drug Application (Generic)

Brand name

IMIPENEM AND CILASTATIN

Generic name

Cilastatin Sodium

Active ingredients

CILASTATIN SODIUM; IMIPENEM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HOSPIRA INC

First approval

2011-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown